Search

Your search keyword '"Scott, Janet"' showing total 171 results

Search Constraints

Start Over You searched for: Author "Scott, Janet" Remove constraint Author: "Scott, Janet" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
171 results on '"Scott, Janet"'

Search Results

1. International Care programs for Pediatric Post-COVID Condition (Long COVID) and the way forward

3. Physical, cognitive, and social triggers of symptom fluctuations in people living with long COVID: an intensive longitudinal cohort study

4. Improving quality in adult long covid services: Findings from the LOCOMOTION quality improvement collaborative

5. Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK

10. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

12. A multi-country analysis of COVID-19 hospitalizations by vaccination status

13. Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study

14. Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

15. Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

16. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

17. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

20. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study

21. Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core Outcome Set development

22. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID)

25. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

27. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

28. Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK

29. Surfactant induced gelation of TEMPO-oxidized cellulose nanofibril dispersions probed using small angle neutron scattering.

30. Prevalence of orthostatic intolerance in long covid clinic patients and healthy volunteers: A multicenter study.

31. Sex differences in post-acute neurological sequelae of SARS-CoV-2 and symptom resolution in adults after coronavirus disease 2019 hospitalization: an international multi-centre prospective observational study.

33. Association of country income level with the characteristics and outcomes of critically ill patients hospitalized with acute kidney injury and COVID-19

34. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

35. Cohort Profile: Post-hospitalisation COVID-19 study (PHOSP-COVID)

36. Supplementary Data from Synchronous Detection of Circulating Tumor Cells in Blood and Disseminated Tumor Cells in Bone Marrow Predicts Adverse Outcome in Early Breast Cancer

37. Data from Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)

40. Supplementary information from Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)

42. Supplementary Data from Clinical Significance of Circulating Tumor Cells in Hormone Receptor–positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab

43. Supplementary Figures from Expanded Genomic Profiling of Circulating Tumor Cells in Metastatic Breast Cancer Patients to Assess Biomarker Status and Biology Over Time (CALGB 40502 and CALGB 40503, Alliance)

44. Data from Molecular Profiling of Tumor Cells in Cerebrospinal Fluid and Matched Primary Tumors from Metastatic Breast Cancer Patients with Leptomeningeal Carcinomatosis

48. Supplementary Figures 1 - 6, Tables 1 - 6 from Molecular Profiling of Tumor Cells in Cerebrospinal Fluid and Matched Primary Tumors from Metastatic Breast Cancer Patients with Leptomeningeal Carcinomatosis

Catalog

Books, media, physical & digital resources